killed enterotoxigenic escherichia coli vaccine

Vaccineexperimental

Clinical trial activity

4 trials · 12 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
2
Phase 3
2
Phase 4
2

Earliest trial started Oct 1, 1998 (NCT02556996)

Timeline

1990s

  1. Jan 1, 1998

    Earliest Phase 3 Sponsor(trial)

Indications

Approved for

Mechanism of action

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • killed enterotoxigenic escherichia coli vaccine

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06588010Phase 3Oct 31, 2024University of Burgundy
NCT06345014Phase 4Dec 20, 2023Aju Pharm, OM Pharma
NCT04049994Phase 4Oct 31, 2019Swiss Paraplegic Centre Nottwil, Swiss Paraplegic Research, Swiss Spinal Cord Injury Cohort Study (SwiSCI)
NCT02556996Phase 3Oct 1, 1998Government of Egypt, International Vaccine Institute, National Institutes of Health (NIH), United States Army, United States Navy, University of Gothenburg
Showing 4 of 4 trials
Page 1 / 1

Organizations

Research & Development (12)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Aju PharmFor profit1112023
Government of EgyptGovernment1011998
International Vaccine InstituteAcademic/Hospital1011998
National Institutes of Health (NIH)Government1011998
OM PharmaFor profit1012023
Swiss Paraplegic Centre NottwilAcademic/Hospital1112019
Swiss Paraplegic ResearchAcademic/Hospital1012019
Swiss Spinal Cord Injury Cohort Study (SwiSCI)Academic/Hospital1012019
United States ArmyGovernment1111998
United States NavyGovernment1011998
University of BurgundyAcademic/Hospital1112024
University of GothenburgAcademic/Hospital1011998
12 organizations
Page 1 / 1